Home
Olav Dahl's picture

Olav Dahl

Professor
  • E-mailOlav.Dahl@uib.no
  • Phone+47 55 97 20 18
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Books
  • Dahl, Olav; Lehne, Gustav; Christoffersen, Thoralf. 2016. Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. 661 pages. ISBN: 978-82-992331-4-9.
  • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein Olav; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. 495 pages. ISBN: 978-829923312-5.
  • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 495 pages. ISBN: 978-82-992331-2-5.
  • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. 495 pages. ISBN: 978-82-9923312-5.
  • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 495 pages. ISBN: 978-829923312-5.
Journal articles
  • Fluge, Øystein; Rekeland, Ingrid Gurvin; Lien, Katarina; Thurmer, Hanne; Borchgrevink, Petter Chr.; Schäfer, Christoph; Sørland, Kari; Assmus, Jörg; Ktoridou-Valen, Irini; Herder, Ingrid; Gotaas, Merethe Otelie Eide; Kvammen, Øivind; Baranowska, Katarzyna Anna; Bohnen, Louis M.L.J.; Martinsen, Sissel; Lonar, Ann Elin; Solvang, Ann-Elise Havnen; Gya, Arne E.S.; Bruland, Ove; Risa, Kristin; Alme, Kine; Dahl, Olav; Mella, Olav. 2019. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine. 170: 585-593. doi: 10.7326/M18-1451
  • Dahl, Olav; Dale, Jon Espen; Brydøy, Marianne. 2018. Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment. Acta Oncologica. 58: 9-20. doi: 10.1080/0284186X.2018.1554259
  • Gaare, Johannes Jernqvist; Sanchez Nido, Gonzalo; Sztromwasser, Pawel Szymon; Knappskog, Per; Dahl, Olav; Lund-Johansen, Morten; Alves, Guido; Tysnes, Ole-Bjørn; Johansson, Stefan; Haugarvoll, Kristoffer; Tzoulis, Charalampos. 2018. No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease. Brain. 141: e16-e16. doi: 10.1093/brain/awx378
  • Gaare, Johannes Jernqvist; Sanchez Nido, Gonzalo; Sztromwasser, Pawel Szymon; Knappskog, Per; Dahl, Olav; Lund-Johansen, Morten; Maple-Grødem, Jodi; Alves, Guido; Tysnes, Ole-Bjørn; Johansson, Stefan; Haugarvoll, Kristoffer; Tzoulis, Charalampos. 2018. Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. Movement Disorders. 33: 1591-1600. doi: 10.1002/mds.64
  • Guren, Marianne; Aagnes, Bjarte; Nygård, Mari; Dahl, Olav; Møller, Bjørn. 2018. Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016. Clinical colorectal cancer. 1-8. doi: 10.1016/j.clcc.2018.10.001
  • Haugnes, Hege Sagstuen; Stenklev, Niels Christian; Brydøy, Marianne; Dahl, Olav; Wilsgaard, Tom; Laukli, Einar; Fosså, Sophie Dorothea. 2018. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. Acta Oncologica. 57: 1075-1083. doi: 10.1080/0284186X.2018.1433323
  • Jacob, Havjin; Stanisavljevic, Luka; Storli, Kristian Eeg; Hestetun, Kjersti Elvestad; Dahl, Olav; Myklebust, Mette Pernille. 2018. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer. Scientific Reports. 8:6157: 1-9. doi: 10.1038/s41598-018-24519-4
  • Dale, Jon Espen; Molinelli, Silvia; Ciurlia, Elisa; Ciocca, Mario; Bonora, Maria; Vitolo, Viviana; Mirandola, Alfredo; Russo, Stefania; Orecchia, Roberto; Dahl, Olav; Fossati, Piero. 2017. Risk of carotid blowout after reirradiation with particle therapy. Advances in Radiation Oncology. 2: 465-474. doi: 10.1016/j.adro.2017.05.007
  • Fjæra, Lars Fredrik; Li, Zuofeng; Ytre-Hauge, Kristian; Muren, Ludvig Paul; Indelicato, Daniel J.; Lassen-Ramshad, Yasmin; Engeseth, Grete May; Brydøy, Marianne; Mairani, Andrea; Flampouri, Stella; Dahl, Olav; Stokkevåg, Camilla Hanquist. 2017. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer. Acta Oncologica. 56: 763-768. doi: 10.1080/0284186X.2017.1314007
  • Jacob, Havjin; Stanisavljevic, Luka; Storli, Kristian Eg; Hestetun, Kjersti Elvestad; Dahl, Olav; Myklebust, Mette Pernille. 2017. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. OncoTarget. 8: 87837-87847. doi: 10.18632/oncotarget.21237
  • Dahl, Alv A; Østby-Deglum, Marie; Oldenburg, Jan; Bremnes, Roy M.; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Fosså, Sophie Dorothea. 2016. Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings. Journal of cancer survivorship. 10: 842-849. doi: 10.1007/s11764-016-0529-4
  • Dale, Jon Espen; Sebjørnsen, Sigrunn; Leh, Sabine Maria; Røsler, Cornelia; Aaserud, Stein; Møller, Bjørn; Fluge, Øystein; Erichsen, Christian; Nadirpour, Saied; Kørner, Hartwig; Pfeffer, Frank; Dahl, Olav. 2016. Multimodal therapy is feasible in elderly anal cancer patients. Acta Oncologica. 56: 81-87. doi: 10.1080/0284186X.2016.1244356
  • Fluge, Øystein; Mella, Olav; Bruland, Ove; Risa, Kristin; Dyrstad, Sissel Elisabeth; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Røsland, Gro Vatne; Fosså, Alexander; Ktoridou-Valen, Irini; Lunde, Sigrid; Sørland, Kari; Lien, Katarina; Herder, Ingrid; Thurmer, Hanne; Gotaas, Merete E; Baranowska, Katarzyna Anna; Bohnen, Louis M.L.J.; Schäfer, Christoph; Mccann, Adrian; Sommerfelt, Kristian; Helgeland, Lars; Ueland, Per Magne; Dahl, Olav; Tronstad, Karl Johan. 2016. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 1. doi: 10.1172/jci.insight.89376
  • Lunde, Sigrid; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Risa, Kristin; Dahl, Olav; Bruland, Ove; Mella, Olav; Fluge, Øystein. 2016. Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. PLoS ONE. 11:e0161226. doi: 10.1371/journal.pone.0161226
  • Pedersen, Kjetil Boye; Jacob, Havjin; Frikstad, Kari-Anne; Nesland, Jahn M; Mælandsmo, Gunhild; Dahl, Olav; Nesbakken, Arild; Flatmark, Kjersti. 2016. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy. Cancer Medicine. 5: 1840-1849. doi: 10.1002/cam4.766
  • Stanisavljevic, Luka; Myklebust, Mette Pernille; Leh, Sabine Maria; Dahl, Olav. 2016. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Acta Oncologica. 55: 1425-1433. doi: 10.1080/0284186X.2016.1201215
  • Tandstad, Torgrim; Ståhl, Olof; Dahl, Olav; Haugnes, Hege Sagstuen; Håkansson, Ulf; Karlsdottir, Åsa; Kjellman, Anders; Langberg, Carl W.; Laurell, Anna; Oldenburg, Jan; Solberg, Arne; Söderström, Karin; Stierner, Ulrika; Cavallin-Ståhl, Eva; Wahlqvist, Rolf; Wall, Najme; Cohn-Cedermark, Gabriella. 2016. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Annals of Oncology. 27: 1299-1304. doi: 10.1093/annonc/mdw164
  • Dahl, Olav; Pfeffer, Frank. 2015. Twenty-five years with adjuvant chemotherapy for colon cancer--a continuous evolving concept. Acta Oncologica. 54: 1-4. doi: 10.3109/0284186X.2014.958533
  • Fluge, Øystein; Risa, Kristin; Lunde, Sigrid; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Kristoffersen, Einar Klæboe; Sørland, Kari; Bruland, Ove; Dahl, Olav; Mella, Olav. 2015. B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PLoS ONE. 10:e0129898. doi: 10.1371/journal.pone.0129898
  • Guren, Marianne; Kørner, Hartwig; Pfeffer, Frank; Myklebust, Tor Åge; Eriksen, Morten Tandberg; Edna, Tom-Harald; Larsen, Stein Gunnar; Knudsen, Kristin O; Nesbakken, Arild; Wasmuth, Hans; Vonen, Barthold; Hofsli, Eva; Færden, Arne Engebret; Brandengen, Morten; Dahl, Olav; Steigen, Sonja Eriksson; Johansen, Magnar; Lindsetmo, Rolv-Ole; Drolsum, Anders; Tollåli, Geir; Dørum, Liv Marit; Møller, Bjørn; Wibe, Arne. 2015. Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncologica. 54: 1714-1722. doi: 10.3109/0284186X.2015.1034876
  • Hestetun, Kjersti Elvestad; Brydøy, Marianne; Myklebust, Mette Pernille; Dahl, Olav. 2015. Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer. Acta Oncologica. 54: 470-479. doi: 10.3109/0284186X.2014.952386
  • Oldenburg, Jan; Haugnes, Hege Sagstuen; Dahl, Olav; Karlsdottir, Åsa; Langberg, Carl W.; Klepp, Olbjørn; Solberg, Arne; Tandstad, Torgrim. 2015. Behandling ved stadium I-testikkelkreft bør vurderes individuelt. Tidsskrift for Den norske legeforening. 135: 1340-1341. doi: 10.4045/tidsskr.15.0544
  • Sakkestad, Sunniva Todnem; Olsen, Bjørn Christian Elias Grova; Karliczek, Anne; Dahl, Olav; Pfeffer, Frank. 2015. Validity of Norwegian Rectal Cancer Registry data at a major university hospital 1997-2005. Acta Oncologica. 54: 1723-1728. doi: 10.3109/0284186X.2015.1031913
  • Stanisavljevic, Luka; Assmus, Jörg; Storli, Kristian Eg; Leh, Sabine Maria; Dahl, Olav; Myklebust, Mette Pernille. 2015. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer. Tumour Biology. 1-12. doi: 10.1007/s13277-015-4591-8
  • Tandstad, Torgrim; Solberg, Arne; Håkansson, Ulf; Stahl, Olof; Haugnes, Hege Sagstuen; Oldenburg, Jan; Dahl, Olav; Kjellman, Anders; Angelsen, Anders; Cohn-Cedermark, Gabriella. 2015. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncologica. 54: 493-499. Published 2014-09-05. doi: 10.3109/0284186X.2014.953256
  • Grotmol, Tom; Karlsson, Robert; Kristiansen, Wenche; Andreassen, Kristine Engen; Aschim, Elin Leirvoll; Dahl, Olav; Fosså, Sophie Dorothea; Tretli, Steinar; Magnusson, Patrik K E; Adami, Hans-Olov; Haugen, Trine B.; Wiklund, Fredrik. 2014. Scandinavian studies of gene variants and risk of testicular germ cell tumor. 8th CIS Abstract book.
  • Krohn, Jørgen Gitlesen; Dahl, Olav; Nybø, Tone; Kjersem, Bård. 2014. J. Krohn og medarbeidere svarer. Tidsskrift for Den norske legeforening. 134: 814. doi: 10.4045/tidsskr.14.0466
  • Krohn, Jørgen Gitlesen; Dahl, Olav; Nybø, Tone; Kjersem, Bård. 2014. Brachytherapy for malignant uveal melanoma. Tidsskrift for Den norske legeforening. 134: 529-529. doi: doi: 10.4045/tidsskr.13.1206
  • Leon, Otilia; Guren, Marianne; Hagberg, Oskar; Glimelius, Bengt; Dahl, Olav; Havsteen, Hanne; Naucler, Gisela; Svensson, Christer; Tveit, Magne Kjell; Jakobsen, Anders; Pfeiffer, Per; Wanderås, Eva Hoff; Ekman, Tor; Lindh, Birgitta; Balteskard, Lise; Frykholm, Gunilla; Johnsson, Anders. 2014. Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiotherapy and Oncology. 113: 352-358. doi: 10.1016/j.radonc.2014.10.002
  • Tandstad, Torgrim; Ståhl, Olof; Håkansson, Ulf; Dahl, Olav; Haugnes, Hege Sagstuen; Klepp, Olbjørn; Langberg, Carl W.; Laurell, Anna; Oldenburg, Jan; Solberg, Arne; Söderström, K; Cavallin-Stahl, E; Stierner, Ulrika; Wahlqvist, Rolf; Wall, Najme; Cohn-Cedermark, G. 2014. One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group. Annals of Oncology. 25: 2167-2172. doi: 10.1093/annonc/mdu375
  • Waldeland, Einar; Dahl, Olav; Odland, Odd Harald; Kvaløy, Stein Olav; Lund, Jo-Åsmund; Malinen, Eirik; Marienhagen, Kirsten; Sylvarnes, Rune; Muren, Ludvig Paul; Pedersen, Geir; Pedersen, Brit; Vadset, Pål Ove; Wanderås, Anne Dybdahl; Mella, Olav. 2014. Particle therapy in Norway - report from the national project group. Radiotherapy and Oncology. 111: 314-314.
  • Andreassen, Kristine Engen; Kristiansen, Wenche; Karlsson, Robert; Aschim, Elin Leirvoll; Dahl, Olav; Fosså, Sophie Dorothea; Adami, Hans Olov; Wiklund, Fredrik; Haugen, Trine Berit; Grotmol, Tom. 2013. Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor. Human Reproduction. 28: 1995-2002. doi: 10.1093/humrep/det127
  • Bentzen, Anne Gry; Balteskard, Lise; Wanderås, Eva Hoff; Frykholm, Gunilla; Wilsgaard, Tom; Dahl, Olav; Guren, Marianne. 2013. Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors. Acta Oncologica. 52: 736-744. doi: 10.3109/0284186X.2013.770599
  • Bentzen, Anne Gry; Guren, Marianne; Vonen, Barthold; Wanderås, Eva Hoff; Frykholm, Gunilla; Wilsgaard, Tom; Dahl, Olav; Balteskard, Lise. 2013. Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort. Radiotherapy and Oncology. 108: 55-60. doi: 10.1016/j.radonc.2013.05.037
  • Grotmol, Tom; Karlsson, Robert; Kristiansen, Wenche; Andreassen, Kristine Engen; Aschim, Elin Leirvoll; Bremnes, Roy M.; Dahl, Olav; Fosså, Sophie Dorothea; Klepp, Olbjørn; Langberg, Carl W.; Solberg, Arne; Tretli, Steinar; Magnusson, Patrik K.E.; Adami, Hans-Olov; Haugen, Trine B.; Wiklund, Fredrik. 2013. Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in the tumor suppressor gene SPRY4. Norsk Epidemiologi, Supplement. 23: 44-44.
  • Karlsson, Robert; Andreassen, Kristine Engen; Kristiansen, Wenche; Aschim, Elin Leirvoll; Bremnes, Roy M.; Dahl, Olav; Fosså, Sophie Dorothea; Klepp, Olbjørn; Langberg, Carl W.; Solberg, Arne; Tretli, Steinar; Magnusson, Patrik K.E.; Adami, Hans Olov; Haugen, Trine Berit; Grotmol, Tom; Wiklund, Fredrik. 2013. Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4. Human Molecular Genetics. 22: 3373-3380. doi: 10.1093/hmg/ddt188
  • Bentzen, Anne Gry; Guren, Marianne; Wanderås, Eva Hoff; Frykholm, Gunilla; Tveit, Magne Kjell; Wilsgaard, Tom; Dahl, Olav; Balteskard, Lise. 2012. Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. International Journal of Radiation Oncology, Biology, Physics. 83: E173-E180. doi: 10.1016/j.ijrobp.2011.12.062
  • Brydøy, Marianne; Fosså, Sophie Dorothea; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Bjøro, Trine; Wentzel-Larsen, Tore; Dahl, Olav. 2012. Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. British Journal of Cancer. 107: 1833-1839. doi: 10.1038/bjc.2012.471
  • Dahl, Olav; Brydøy, Marianne. 2012. Testicular germ cell tumours - still many challenges. Acta Oncologica. 51: 147-150. doi: 10.3109/0284186X.2011.653441
  • Haugnes, Hege Sagstuen; Laurell, Anna; Stierner, Ulrika; Bremnes, Roy M.; Dahl, Olav; Cavallin-Ståhl, Eva; Cohn-Cedermark, Gabriella. 2012. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). Acta Oncologica. 51: 168-176. doi: 10.3109/0284186X.2011.641507
  • Kristiansen, Wenche; Andreassen, Kristine Engen; Karlsson, Robert; Aschim, Elin Leirvoll; Bremnes, Roy M.; Dahl, Olav; Fosså, Sophie Dorothea; Klepp, Olbjørn; Langberg, Carl W.; Solberg, Arne; Tretli, Steinar; Adami, Hans-Olov; Wiklund, Fredrik; Grotmol, Tom; Haugen, Trine Berit. 2012. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. Human Reproduction. 27: 1525-1535. doi: 10.1093/humrep/des075
  • Myklebust, Mette Pernille; Fluge, Øystein; Immervoll, Heike; Skarstein, Arne; Balteskard, Lise; Bruland, Ove; Dahl, Olav. 2012. Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. British Journal of Cancer. 106: 756-762. doi: 10.1038/bjc.2011.548
  • Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H.; Rui, Hallgeir; Knudsen, Erik S.; Elsaleh, Hany; Fluge, Øystein; Vonen, Barthold; Myrvold, Helge Elliot; Leh, Sabine; Tveit, Magne Kjell; Pestell, Richard G.; Dahl, Olav. 2012. Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer. 107: 1684-1691. doi: 10.1038/bjc.2012.463
  • Rades, Dirk; Setter, Cornelia; Dahl, Olav; Schild, Steven E.; Noack, Frank. 2012. Fibroblast growth factor 2—A predictor of outcome for patients irradiated for stage II-III non–small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 82: 442-447. doi: 10.1016/j.ijrobp.2010.08.048
  • Rades, Dirk; Setter, Cornelia; Dahl, Olav; Schild, Steven E.; Noack, Frank. 2012. The prognostic impact of tumor cell expression of estrogen receptor-alpha, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. Cancer. 118: 157-163. doi: 10.1002/cncr.26282
  • Tandstad, Torgrim; Solberg, Arne; Håkansson, Ulf; Angelsen, Anders; Haugnes, Hege Sagstuen; Oldenburg, Jan; Kjellman, Anders; Dahl, Olav; Cohn-Cedermark, Gabriella. 2012. Bilateral testicular cancer within two prospective, population-based SWENOTECA protocols in clinical stage I nonseminoma. Journal of Clinical Oncology. 30. 1 pages.
  • Tveit, Magne Kjell; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, Per; Sorbye, Halfdan; Pyrhonen, Seppo; Sigurðsson, Friðbjörn; Kure, Elin H.; Andersen, Tone Ikdahl; Skovlund, Eva; Fokstuen, Tone; Hansen, Flemming; Hofsli, Eva; Birkemeyer, Elke; Johnsson, Anders; Starkhammar, Hans; Yilmaz, Mette Karen; Keldsen, Nina; Erdal, Anne Berit Rødal; Dajani, Olav; Dahl, Olav; Christoffersen, Thoralf. 2012. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII Study. Journal of Clinical Oncology. 30: 1755-1762. doi: 10.1200/JCO.2011.38.0915
  • Westermann, Anneke; Mella, Olav; Van der Zee, Jacoba; Jones, Ellen L.; Van der Steen-Banasik, Elzbieta; Koper, Peter; Uitterhoeve, Appolina L.J.; de Wit, Ronald; van der Velden, Jacobus; Burger, Curt; Schem, Baard-Christian; Van der Wilt, Clasina L.; Dahl, Olav; Prosnitz, Leonard R.; van Tinteren, Harm. 2012. Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update. International Journal of Hyperthermia. 28: 549-553. doi: 10.3109/02656736.2012.673047
  • Balteskard, Lise; Dahl, Olav; Guren, Marianne; Haraldsen, Mathilde; Strickert, Trond; Wanderås, Eva Hoff; Heikkilä, Ingrid Espe; Hellebust, Taran Paulsen; Frykholm, Gunilla. 2011. Faglige anbefalinger for behandling ved analcancer. StrålevernRapport. 5: 1-34.
  • Fluge, Øystein; Bruland, Ove; Risa, Kristin; Storstein, Anette; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Næss, Halvor; Dahl, Olav; Nyland, Harald Inge; Mella, Olav. 2011. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS ONE. 6. 13 pages. doi: 10.1371/journal.pone.0026358
  • Myklebust, Mette Pernille; Bruland, Ove; Fluge, Øystein; Skarstein, Arne; Balteskard, Lise; Dahl, Olav. 2011. MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. British Journal of Cancer. 105: 1719-1725. doi: 10.1038/bjc.2011.457
  • Olofsson, Sven-Erik; Tandstad, Torgrim; Jerkeman, Mats; Dahl, Olav; Ståhl, Olof; Klepp, Olbjørn; Bremnes, Roy M.; Cohn-Cedermark, Gabriella; Langberg, Carl W.; Laurell, Anna; Solberg, Arne; Stierner, Ulrika; Wahlqvist, Rolf; Wijkström, Hans; Anderson, Harald; Cavallin-Ståhl, Eva. 2011. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian testicular cancer group. Journal of Clinical Oncology. 29: 2032-2039. doi: 10.1200/JCO.2010.29.1278
  • Rades, Dirk; Setter, Cornelia; Dahl, Olav; Schild, Steven E.; Noack, Frank. 2011. Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 80: 499-505. doi: 10.1016/j.ijrobp.2010.02.003
  • Tandstad, Torgrim; Smaaland, Rune; Solberg, Arne; Bremnes, Roy M.; Langberg, Carl W.; Laurell, Anna; Stierner, Ulrika; Ståhl, Olof; Cavallin-Ståhl, Eva; Klepp, Olbjørn; Dahl, Olav; Cohn-Cedermark, Gabriella. 2011. Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group. Journal of Clinical Oncology. 29: 719-725. doi: 10.1200/JCO.2010.30.1044
  • BRUHEIM, KJERSTI; Guren, Marianne; Skovlund, Eva; Hjermstad, Marianne Jensen; Dahl, Olav; Frykholm, Gunilla; Carlsen, Erik; Tveit, Magne Kjell. 2010. Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 76: 1005-1011. doi: 10.1016/j.ijrobp.2009.03.010
  • Bruheim, K; Guren, MG; Skovlund, E; Hjermstad, Marianne Jensen; Dahl, O; Frykholm, Gunilla; Carlsen, Erik; Tveit, KM. 2010. Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 76: 1005-1011. doi: 10.1016/j.ijrobp.2009.03.010
  • Brydøy, Marianne; Fosså, Sophie D; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Wentzel-Larsen, Tore; Dahl, Olav. 2010. Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy. European Urology. 58: 134-140. doi: 10.1016/j.eururo.2010.03.041
  • Dahl, Christian Falk; Haugnes, Hege Sagstuen; Bremnes, Roy M.; Dahl, Olav; Fosså, Sophie Dorothea; Klepp, Olbjørn; Wist, Erik; Dahl, Alv A. 2010. A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors. Journal of cancer survivorship. 4: 256-265. doi: 10.1007/s11764-010-0133-y
  • Haugnes, Hege Sagstuen; Wethal, Torgeir; Aass, Nina Kathrine; Dahl, Olav; Klepp, Olbjørn; Langberg, Carl W.; Wilsgaard, Tom; Bremnes, Roy M.; Fosså, Sophie Dorothea. 2010. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. Journal of Clinical Oncology. 28: 4649-4657. doi: 10.1200/JCO.2010.29.9362
  • Kvåle, Rune; Møller, Bjørn; Angelsen, Anders; Dahl, Olav; Fosså, Sophie Dorothea; Halvorsen, Ole Johan; Hoem, Lars; Solberg, Anette; Wahlqvist, Rolf; Bray, Freddie Ian. 2010. Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007. Cancer Detection and Prevention. 34: 359-367. doi: 10.1016/j.canep.2010.04.017
  • Li, Zhiping; Jiao, Xuanmao; Wang, Chenguang; Shirley, L. Andrew; Elsaleh, Hany; Dahl, Olav; Wang, Min; Soutoglou, Evi; Knudsen, Erik S.; Pestell, Richard G. 2010. Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response. Cancer Research. 70: 8802-8811. doi: 10.1158/0008-5472.CAN-10-0312
  • Rades, Dirk; Setter, Cornelia; Dunst, Jürgen; Dahl, Olav; Schild, Steven E.; Noack, Frank. 2010. Prognostic Impact of VEGF and VEGF Receptor 1 (FLT1) Expression in Patients Irradiated for Stage II/III Non-Small Cell Lung Cancer (NSCLC). Strahlentherapie und Onkologie (Print). 186: 307-314. doi: 10.1007/s00066-010-2131-4
  • Rutskij, Robert; Gaarden, Torfinn; Bremnes, R; Dahl, Olav; Finset, Arnstein; Fosså, Sophie Dorothea; Klepp, O; Sørebø, Øystein; Wist, Erik; Dahl, Alv A. 2010. A study of coping in long-term testicular cancer survivors. Psychology, Health & Medicine. 15: 146-158. doi: 10.1080/13548501003623955
  • Tandstad, Torgrim; Cohn-Cedermark, Gabriella; Dahl, Olav; Stierner, Ulrika; Cavallin-Ståhl, Eva; Bremnes, Roy M.; Klepp, Olbjørn. 2010. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Annals of Oncology. 21: 1858-1863. doi: 10.1093/annonc/mdq026
  • Bass, Adam J; Watanabe, Hideo; Mermel, Craig; Yu, Soyoung; Perner, Sven; Verhaak, Roel G; Kim, So Young; Tamayo, P; Gat-Viks, I; Ramos, AH; Woo, MS; Weir, BA; Getz, G; Beroukim, R; O'Kelly, M; Dutt, A; Rosenblatt-Rosen, O; Dziunycz, P; Komisarof, J; Chirieac, LR; LaFargue, CJ; Scheble, V; Wilbertz, T; Ma, C; Rao, S; Nakagawa, H; Stairs, DB; Lin, L; Giordiano, TJ; Wagner, P; Minna, JD; Gazdar, AF; Zhu, CQ; Brose, MS; Cecconello, I; Ribeiro Jr, U; Marie, SK; Dahl, Olav; Shivdasani, RA; Tsao, MS; Rubin, MA; Wong, KK; Regev, A; Hahn, WC; Beer, DG; Rustgi, AK; Meyerson, M. 2009. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics. 41: 1238-1242. doi: 10.1038/ng.465
  • Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove; Fluge, Øystein. 2009. Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. International Journal of Hyperthermia. 25: 41-46. doi: 10.1080/02656730802397955
  • Borkamo, Erling Dahl; Schem, Baard-Christian; Fluge, Øystein; Bruland, Ove; Dahl, Olav; Mella, Olav. 2009. cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 75: 1562-1569. doi: 10.1016/j.ijrobp.2009.08.007
  • Brydøy, Marianne; Oldenburg, J; Oldenburg, Jan; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Wentzel-Larsen, Tore; Hauge, Erik R; Hauge, Erik R; Dahl, Olav; Fosså, Sophie D. 2009. Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. 101: 1682-1695. doi: 10.1093/jnci/djp413
  • Brydøy, Marianne; Oldenburg, Jan; Klepp, Olbjørn; Bremnes, Roy M.; Wist, E.; Wentzel-Larsen, Tore; Hauge, Erik R.; Dahl, Olav; Fosså, Sophie D. 2009. Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. 101: 1682-1695.
  • Christoffersen, Thoralf; Guren, Tormod K.; Spindler, Karen-Lise Garm; Dahl, Olav; Lønning, Per Eystein; Gjertsen, Bjørn Tore. 2009. Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues. European Journal of Pharmacology. 625: 6-22. doi: 10.1016/j.ejphar.2009.10.009
  • Dahl, Olav. 2009. Follow up your unexpected clinical observations! Acta Oncologica. 48: 325-327. doi: 10.1080/02841860902740915
  • Dahl, Olav; Fluge, Øystein; Carlsen, Erik; Wiig, Johan N; Myrvold, Helge E; Vonen, Barthold; Podhorny, Nina; Bjerkeset, Ottar; Eide, Tor Jacob; Halvorsen, T; Tveit, Kjell Magne. 2009. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica. 48: 368-376. doi: 10.1080/02841860902755244
  • Fluge, Øystein; Gravdal, K; Carlsen, E; Carlsen, Erik; Vonen, Barthold; Kjellevold, K; Refsum, S; Lilleng, R; Eide, Tor J.; Halvorsen, TB; Tveit, KM; Tveit, Kjell Magne; Otte, AP; Akslen, LA; Dahl, O. 2009. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer. 101: 1282-1289. doi: 10.1038/sj.bjc.6605333
  • Grov, EK; Grov, EK; Fossa, SD; Fosså, Sophie D; Bremnes, Roy M.; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Dahl, Alv A. 2009. The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors. Acta Oncologica. 48: 842-849. doi: 10.1080/02841860902795232
  • Haugnes, Hege Sagstuen; Aass, Nina; Fosså, Sophie D; Dahl, Olav; Brydøy, Marianne; Aasebø, Ulf; Wilsgaard, Tom; Bremnes, Roy M. 2009. Pulmonary Function in Long-Term Survivors of Testicular Cancer. Journal of Clinical Oncology. 27: 2779-2786. doi: 10.1200/JCO.2008.18.5181
  • Jullumstrø, Eivind; Lydersen, Stian; Møller, Bjørn; Møller, Bjørn; Dahl, Olav; Edna, Tom-Harald. 2009. Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. European Journal of Cancer. 45: 2383-2390. doi: 10.1016/j.ejca.2009.03.014
  • Karlsdóttir, Ása; Muren, Ludvig Paul; Wentzel-Larsen, Tore; Johannessen, Dag Clement; Haukaas, Svein Andreas; Halvorsen, Ole Johan; Dahl, Olav. 2009. Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. Acta Oncologica. 48: 874-881. doi: 10.1080/02841860902974159
  • Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav. 2009. Topographical distribution of choroidal naevi in the ocular fundus. Eye (London. 1987). 23: 1685-1690. doi: 10.1038/eye.2008.350
  • Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav. 2009. Topography of solitary congenital hypertrophy of the retinal pigment epithelium in the ocular fundus. Acta Ophthalmologica. 87: 921-922. doi: 10.1111/j.1755-3768.2009.01539.x
  • Olofsson, Sven-Erik; Dahl, Olav; Jerkeman, Mats; Cohn-Cedermark, Gabriella; Klepp, Olbjørn; Stierner, Ulrika; Törnblom, Marianne; Wahlqvist, Rolf; Cavallin-Ståhl, Eva. 2009. Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA. Journal of Clinical Oncology. 27. 2 pages.
  • Overgaard, Jens; Gonzalez-Gonzales, Dionisio; Hulshof, Maarten C.C.H.; Arcangeli, Giorgio; Dahl, Olav; Mella, Olav; Bentzen, Søren M. 2009. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicenter randomized trial by The European Society for Hyperthermic Oncology. International Journal of Hyperthermia. 25: 323-334. doi: 10.1080/02656730903091986
  • Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav; Skarstein, Arne; Søreide, Jon Arne. 2009. Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. Colorectal Disease. 11: 838-844. doi: 10.1111/j.1463-1318.2008.01700.x
  • Sigurdsson, Helgi Kjartan; Søreide, Jon Arne; Dahl, Olav; Skarstein, Arne; von Hofacker, Sebastian; Kørner, Hartwig. 2009. Utilisation of specialist care in patients with incurable rectal cancer. A population-based study from Western Norway. Acta Oncologica. 48: 377-384. doi: 10.1080/02841860802468104
  • Skaali, Tone; Skaali, T; Fossa, SD; Fosså, Sophie D; Bremnes, Roy M.; Dahl, Olav; Haaland, CF; Hauge, ER; Klepp, Olbjørn; oldenburg, j; Oldenburg, Jan; Wist, Erik; Dahl, Alv A. 2009. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 18: 580-588. doi: 10.1002/pon.1437
  • Tandstad, T; Dahl, Olav; Cohn-Cedermark, G; Cavallin-Stahl, E; Cavellin-Ståhl, Eva; Stierner, U; Solberg, A; Langberg, C; Bremnes, Roy M.; Laurell, A; Wijkstrøm, H; Klepp, Olbjørn. 2009. Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program. Journal of Clinical Oncology. 27: 2122-2128. doi: 10.1200/JCO.2008.18.8953
  • Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove; Fluge, Øystein. 2008. Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. International Journal of Hyperthermia. 24: 425-441. doi: 10.1080/02656730802081997
  • Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav; Akslen, Lars A.; Bruland, Ove; Dahl, Olav. 2008. Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. Radiotherapy and Oncology. 86: 435-442. doi: 10.1016/j.radonc.2008.01.022
  • Bruland, Ove; Fluge, Øystein; Immervoll, Heike; Balteskard, Lise; Myklebust, Mette Pernille; Skarstein, Arne; Dahl, Olav. 2008. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. British Journal of Cancer. 98: 1264-1273. doi: 10.1038/sj.bjc.6604285
  • Dahl, Olav. 2008. 2008 ESHO-BSD award winner - Gerard C. van Rhoon. International Journal of Hyperthermia. 24: 444-445. doi: 10.1080/02656730802383997
  • Dahl, Olav; Borkamo, Erling Dahl; Fluge, Øystein. 2008. Current status of antivascular therapy and targeted treatment in the clinic. International Journal of Hyperthermia. 24: 97-110. doi: 10.1080/02656730701824406
  • Dahl, Olav; Fluge, Øystein. 2008. Analkreft. Tidsskrift for Den norske legeforening. 128: 198-200.
  • Haugnes, Hege Sagstuen; Aass, Nina; Fosså, SD; Dahl, Olav; Klepp, Olbjørn; Wist, EA; Wilsgård, Tom; Bremnes, RM. 2008. Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. Journal of cancer survivorship. 2: 128-137. doi: 10.1007/s11764-008-0054-1
  • Haugnes, Hege Sagstuen; Aass, Nina; Fosså, Sophie D; Dahl, Olav; Brydøy, Marianne; Aasebø, Ulf; Wilsgaard, Tom; Bremnes, Roy M. 2008. Pulmonary function in long-term testicular cancer survivors. Annals of Oncology. 19: viii205.
  • Haugnes, Hege Sagstuen; Aass, Nina; Fosså, Sophie D; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Wilsgaard, Tom; Bremnes, Roy M. 2008. Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. Journal of cancer survivorship. 2: 128-137.
  • Karlsdóttir, Ása; Muren, Ludvig Paul; Wentzel-Larsen, T.; Dahl, Olav. 2008. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. International Journal of Radiation Oncology, Biology, Physics. 70: 1478-1486. doi: 10.1016/j.ijrobp.2007.08.076
  • Krohn, Jørgen Gitlesen; Dahl, Olav. 2008. Incidence of iris melanoma in western Norway. Acta Ophthalmologica. 86: 116-117. doi: 10.1111/j.1600-0420.2007.01011.x
  • Krohn, Jørgen Gitlesen; Dahl, Olav. 2008. Incidence of iris melanoma in western Norway. Acta Ophthalmologica. 86: 116-117. doi: 10.1111/j.1600-0420.2007.01011.x
  • Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav. 2008. Posterior uveal melanoma. Distribution of the sites of origin and patterns of tumour extent in the ocular fundus. British Journal of Ophthalmology. 92: 751-756. doi: 10.1136/bjo.2007.133025
  • Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav. 2008. Topographical distribution of posterior uveal melanoma, choroidal nevi, and congenital hypertrophy of the retinal pigment epithelium. Acta Ophthalmologica. 86: 8-8. doi: 10.1111/j.1755-3768.2008.01272.x
  • Krohn, Jørgen Gitlesen; Monge, Odd R.; Skorpen, Tone Nybø; Mørk, Sverre; Dahl, Olav. 2008. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. Eye (London. 1987). 22: 1398-1403. doi: 10.1038/sj.eye.6702911
  • Orre, IJ; Fosså, Sophie Dorothea; Fossa, SD; Murison, Robert; Bremnes, Roy M.; Dahl, Olav; Klepp, Olbjørn; Loge, JH; Wist, EA; Dahl, Alv A. 2008. Chronic cancer-related fatigue in long-term survivors of testicular cancer. Journal of Psychosomatic Research. 64: 363-371. doi: 10.1016/j.jpsychores.2008.01.002
  • Røe, Kathrine; Muren, Ludvig Paul; Rørvik, Jarle; Olsen, Dag Rune; Dahl, Olav; Bakke, August; Malinen, Eirik. 2008. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. 47: 1257-1264. doi: 10.1080/02841860802244174
  • Røe, Kathrine; Muren, Ludvig; Rørvik, Jarle; Olsen, Dag Rune; Dahl, Olav; Bakke, August; Malinen, Eirik. 2008. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. 47: 1257-1264. doi: 10.1080/02841860802244174
  • Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav; Skarstein, Arne; Søreide, Jon Arne. 2008. Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. Colorectal Disease. 23 pages.
  • Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav; Skarstein, Arne; Søreide, Jon Arne. 2008. Palliative surgery for rectal cancer in a national cohort. Colorectal Disease. 10: 336-343. doi: 10.1111/j.1463-1318.2007.01376.x
  • Skaali, T; Fosså, Sophie Dorothea; Bremnes, R; Dahl, Olav; Haaland, Carl Fredrik; Hauge, Erik R; Klepp, Olbjørn; Oldenburg, Jan; Wist, Erik; Dahl, Alv A. 2008. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. doi: 10.1002/pon.1437
  • Balteskard, L; Vonen, Barthold; Frykholm, Gunilla; Dahl, Olav; Tveit, KM. 2007. Strålebehandling av endetarmskreft. Tidsskrift for Den norske legeforening. 127: 3090-3093.
  • Bremnes, Roy M.; Grov, Ellen Karine; Fossa, SD; Klepp, O; Fosså, Sophie D.; Dahl, Alv A; Dahl, Olav; Wist, Erik A.; Dahl, AA. 2007. Is neuroticism associated with long-term morbidity in testicular cancer survivors? Psycho-Oncology. 16.
  • Brydøy, Marianne; Brydoy, M; Fosså, Sophie D.; Dahl, Olav; Bjoro, T; Bjøro, Trine. 2007. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncologica. 46: 480-489. doi: 10.1080/02841860601166958
  • Brydøy, Marianne; Storstein, Anette Margrethe; Dahl, Olav. 2007. Transient neurological adverse effects following low dose radiation therapy for early stage testicular seminoma. Radiotherapy and Oncology. 82: 137-144. doi: 10.1016/j.radonc.2006.11.022
  • Dahl, Alv A; Bremnes, Roy M.; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Fosså, Sophie D; Fossa, SD. 2007. Is the sexual function compromised in long-term testicular cancer survivors? European Urology. 52: 1438-1447. doi: 10.1016/j.eururo.2007.02.046
  • Dahl, Olav. 2007. Adjuvant kjemoterapi ved tykktarmskreft. Tidsskrift for Den norske legeforening. 127: 3094-3096.
  • Larsen, Annette; Bjørge, Benedikte; Klementsen, Beate; Helgeland, Lars Inge; Wentzel-Larsen, Tore; Fagerhol, Magne K; Hovdenak, Nils; Dahl, Olav. 2007. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncologica. 46: 639-650. doi: 10.1080/02841860601099241
  • Larsen, Annette; Bronstein, Igor B.; Dahl, Olav; Wentzel-Larsen, Tore; Kristoffersen, Einar Klæboe; Fagerhol, Magne K. 2007. Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. Scandinavian Journal of Immunology. 65: 192-201. doi: 10.1111/j.1365-3083.2006.01875.x
  • Sagstuen, hege; Aass, N; Fosså, Sophie D.; Fossa, SD; Dahl, O; Klepp, O; Wist, EA; Svartberg, Johan; Wilsgaard, Tom; Bremnes, Roy M. 2007. Components of the metabolic syndrome in long-term survivors of testicular cancer. Annals of Oncology. 18: 241-248. doi: 10.1093/annonc/mdl372
  • Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav; Skarstein, Arne; Søreide, Jon Arne. 2007. Clinical characteristics and outcomes in patients with advanced rectal cancer: A national prospective cohort study. Diseases of the Colon & Rectum. 50: 285-291. doi: 10.1007/s10350-006-0770-4
  • Skaali, T; Fossa, SD; Bremnes, Roy M.; Dahl, O; Klepp, O; Wist, E; Dahl, AA; Dahl, AA. 2007. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 16.
  • Bremnes, Roy M.; Sagstuen, hege; Aass, N; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Wilsgaard, Tom; Fosså, SD. 2006. Cardiovascular (CV)morbidity and predicted mortality in long-term testicular cancer (TC) survivors. Annals of Oncology. 17: 443PD.
  • Brydøy, Marianne; Oldenburg, Johannes; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik A.; Dahl, Olav; Fosså, Sophie D. 2006. Self-reported paresthesias, Raynaud's phenomena, tinnitus, and hearing impairment in a large cohort of long-term testicular cancer (TG) survivors. Journal of Clinical Oncology. 24: 228S-228S.
  • Brydøy, Marianne; oldenburg, j; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Dahl, Olav; Fosså, SD. 2006. Self-reported paresthesia, Raynaud,s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. Journal of Clinical Oncology. 24: 228s.
  • Karlsdottir, A; Muren, Ludvig Paul; Wentzel-Larsen, T.; Johannessen, DC; Øgreid, Per; Halvorsen, Ole Johan; Dahl, Olav. 2006. Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer. Acta Oncologica. 45: 454-462.
  • Muren, Ludvig Paul; Redpath, Anthony Thomas; McLaren, Duncan; Rørvik, Jarle; Halvorsen, Ole Johan; Høstmark, Jens Gerhard; Bakke, August; Thwaites, David; Dahl, Olav. 2006. A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. Radiotherapy and Oncology. 80: 98-105. doi: 10.1016/j.radonc.2006.06.015
  • Sagstuen, hege; Aass, N; Fosså, Sophie D; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Svartberg, Johan; Wilsgaard, Tom; Bremnes, Roy M. 2006. Components of the metabolic syndrome in long-term survivors of testicular cancer. Annals of Oncology. Published 2006-10-23.
  • Brydoy, M; Fossa, SD; Klepp, Olbjørn; Bremnes, R; Wist, EA; Wentzel-Larsen, T; Dahl, O. 2005. Paternity following treatment for testicular cancer. Journal of the National Cancer Institute. 97: 1580-1588.
  • Brydøy, M; Fosså, Sophie Dorothea; Klepp, Olbjørn; Bremnes, Roy; Wist, Erik; Wentzel-Larsen, T; Dahl, Olav. 2005. Paternity following treatment for testicular cancer. Journal of the National Cancer Institute. 97: 1580-1588.
  • Brydøy, Marianne; Fosså, SS; Bremnes, Roy M.; Klepp, Olbjørn; Wist, Erik; Dahl, Olav. 2005. Self-reported paresthesia, Raynaud’s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. European Journal of Cancer. 3.
  • Brydøy, Marianne; Fosså, Sophie D.; Bremnes, Roy; Klepp, Olbjørn; Wist, Erik; Dahl, Olav. 2005. Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer. European Journal of Cancer. 3: 228s.
  • Brydøy, Marianne; Fosså, Sophie D.; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik A.; Wentzel-Larsen, Tore; Dahl, Olav. 2005. Paternity Following Treatment for Testicular Cancer. Journal of the National Cancer Institute. 97: 1580-1588. doi: 10.1093/jnci/dji339
  • Brydøy, Marianne; Fosså, Sophie D; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Wentzel-Larsen, Tore; Dahl, Olav. 2005. Paternity following treatment for testicular cancer. Journal of the National Cancer Institute. 97: 1580-1588.
  • Dahl, Alv A; Haaland, Carl Fredrik; Mykletun, Anstein; Bremnes, Roy M.; Dahl, Olav; Dahl, Carl Bredo; Klepp, Olbjørn; Wist, Erik; Fossa, SD; Fosså, Sophie D. 2005. Study of anxiety disorder and depression in long-term survivors of testicular cancer. Journal of Clinical Oncology. 23: 2389-2395.
  • Dahl, Olav. 2005. Protons. A step forward or perhaps only more expensive radiation therapy? Acta Oncologica. 44: 798-800.
  • Dahl, Olav. 2005. First things first. Acta Oncologica. 44: 11-12.
  • Dahl, Olav. 2005. Clinical hyperthermia combined with radiation is safe. International Journal of Hyperthermia. 21: 193-197.
  • Glimelius, B; Dahl, O; Cedermark, B; Jakobsen, A; Bentzen, SM; Starkhammar, H; Grunberg, H; Hultborn, R; Albertsson, M; Pahlman, L; Tveit, Magne Kjell. 2005. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica. 44(8): 904-912.
  • Glimelius, Bengt; Dahl, Olav; Cedermark, Björn; Jakobsen, Anders; Benzen, Søren M.; Starkhammar, Hans; Grönberg, Henrik; Hultborn, Ragnar; Albertsson, Maria; Påhlman, Lars; Tveit, Kjell-Magne. 2005. Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica. 44: 904-912. doi: 10.1080/02841860500355900
  • Hovdenak, Nils; Sørbye, Halfdan; Dahl, Olav. 2005. SSucralfate does not ameliorate acute radiation proctitis: Randomised study and meta-analysis. Clinical Oncology. 17: 485-491. doi: 10.1016/j.clon.2005.04.011
  • Muren, Ludvig Paul; Karlsdóttir, Ása; Wentzel-Larsen, Tore; Kvinnsland, Yngve; Dahl, Olav. 2005. Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum. Radiotherapy and Oncology. 75: 293-302. doi: 10.1016/j.radonc.2005.03.007
  • Mykletun, A; Dahl, Alv A; Haaland, Carl Fredrik; Bremnes, Roy M.; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Fosså, Sophie D; Fossa, SD. 2005. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. Journal of Clinical Oncology. 23: 3061-3068.
  • Sagstuen, Hege; Aass, Nina; Aass, Nina Kathrine; Fosså, Sophie D; Dahl, O; Klepp, Olbjørn; Wist, Erik; Svartberg, Johan; Wilsgaard, Tom; Bremnes, Roy M. 2005. Metabolic syndrome in long-term testicular cancer survivors. Journal of Clinical Oncology. 23.
  • Sagstuen, Hege; Aass, Nina; Fosså, Sophie D; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Wilsgaard, Tom; Svartberg, Johan. 2005. Metabolic syndrome in long-term testicular cancer survivors. Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 24.
  • Sagstuen, Hege; Aass, Nina; Fosså, Sophie D; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Wilsgård, T; Wilsgaard, Tom; Bremnes, Roy M. 2005. Blood pressure and body mass index in long-term survivors of testicular cancer. Journal of Clinical Oncology. 23: 4980-4990.
  • Thorsen, L; Nystad, W; Dahl, Olav; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Fosså, Sophie D. 2005. The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Supportive Care in Cancer. 13: 637-646.
  • Thorsen, L; Nystad, W; Stigum, H; Dahl, O; Klepp, Olbjørn; Bremnes, R; Wist, E; Fossa, SD. 2005. The assosiation between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men i general population sample. Supportive Care in Cancer. 13: 637-646.
  • Thorsen, Lene; Nystad, W; Stigum, H; Dahl, Olav; Klepp, Olbjørn; Bremnes, Roy; Wist, Erik; Fosså, Sophie Dorothea. 2005. The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Supportive Care in Cancer. 13: 637-646.
  • Thorsen, Lene; Nystad, Wenche; Stigum, Hein; Dahl, Olav; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Fosså, Sophie D. 2005. The association between self-reported physical activity and prevalence of depression and anxiety disorders in long-term survivors of testicular cancer and men in the general population sample. Supportive Care in Cancer. 13: 637-646. doi: 10.1007/s00520-004-0769-0
  • Balteskard, L; Bremnes, Roy M.; Dahl, O; Klepp, O; Wist, E; Fosså, Sophie D. 2004. Working ability and educational level among long-term survivors of teasticular cancer (TCSS) compared to a general population (GenPop). Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 23. 1 pages.
  • Baumann, M; Leer, J.W.H.; Dahl, Olav; De Neve, W; Hunter, R; Rampling, R; Verfaillie, C. 2004. Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within Europe. Radiotherapy and Oncology. 70: 107-113.
  • Brydøy, Marianne; Fossa, S; Klepp, Olbjørn; Wist, Erik; Bremnes, Roy; Dahl, Olav. 2004. Post-treatment paternity in testicular cancer survivors. Journal of Clinical Oncology. 22: 388S-388S.
  • Brydøy, Marianne; Fosså, Sophie D; Klepp, Olbjørn; Wist, Erik; Bremnes, Roy M.; Dahl, Olav. 2004. Post-treatment paternity in testicular cancer survivors. Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 23. 1 pages.
  • Dahl, Olav; Aarseth, J; Myhr, Kjell-Morten; Nyland, Harald Inge; Midgard, Rune. 2004. Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. Acta Neurologica Scandinavica. 109: 378-384.
  • Eikesdal, Hans Petter; Straume, Oddbjørn; Akslen, Lars A.; Dahl, Olav. 2004. Karnydanning og tumorkar som mål for kreftterapi. Tidsskrift for Den norske legeforening. 124: 1919-1922.
  • Karlsdottir, Åsa; Johannessen, Dag Clement; Muren, Ludvig Paul; Wentzel-Larsen, Tore; Dahl, Olav. 2004. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiotherapy and Oncology. 71: 43-53.
  • Kvinnsland, Yngve; Muren, Ludvig Paul; Dahl, Olav. 2004. Evaluation of a new method for calculation of cumulative doses in the rectum wall using repeat CT scans. Acta Oncologica. 43: 388-395.
  • Kvinnsland, Yngve; Muren, Ludvig Paul; Dahl, Olav. 2004. A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter. Physics in Medicine and Biology. 49: 3341-3352.
  • Larsen, Annette; Hovdenak, Nils; Karlsdottir, Åsa; Wentzel-Larsen, Tore; Dahl, Olav; Fagerhol, M. K. 2004. Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: A pilot study of eight stool markers. Scandinavian Journal of Gastroenterology. 39: 1113-1118. doi: 10.1080/00365520410003614
  • Muren, Ludvig Paul; Ekerold, R; Kvinnsland, Yngve; Karlsdottir, Åsa; Dahl, Olav. 2004. On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning. Radiotherapy and Oncology. 70: 11-19.
  • Muren, Ludvig Paul; Karlsdottir, Åsa; Kvinnsland, Yngve; Wentzel-Larsen, Tore; Dahl, Olav. 2004. Testing the new ICRU 62 'planning organ at risk volume' concept for the rectum. Radiotherapy and Oncology. 73.
  • Muren, Ludvig Paul; Småland, Rune; Dahl, Olav. 2004. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiotherapy and Oncology. 69: 291-304.
  • Muren, Ludvig Paul; Småland, Rune; Dahl, Olav. 2004. Conformal radiotherapy of urinary bladder cancer. Radiotherapy and Oncology. 73: 387-398.
  • Sagstuen, Hege; Aass, N; Fosså, Sophie D; Klepp, O; Wist, E; Dahl, O; Wilsgaard, Tom; Bremnes, Roy M. 2004. Blood pressure and body mass index (BMI) in testicular cancer survivors. Annals of Oncology. 15: 112-112.
  • Sagstuen, Hege; Aass, Nina Kathrine; Fosså, Sophie Dorothea; Klepp, Olbjørn; Wist, Erik; Dahl, Olav; Wilsgård, Tom; Bremnes, Roy. 2004. Blood pressure and body mass index (BMI) in testicular cancer survivors. Annals of Oncology. 15: 112-112.
  • Sørbye, Halfdan; Dahl, Olav. 2004. Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. Acta Oncologica. 43: 495-498.
  • Sørbye, Halfdan; Glimelius, Bengt; Berglund, Å; Fokstuen, T; Tveit, Kjell Magne; Brændengen, M; Øgreid, D; Dahl, Olav. 2004. Multicentre phase II study of Nordic 5-fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology. 22: 31-38.
  • Arnesen, Harald; Dahl, O; Aspelin, Trude; Seljeflot, Ingebjørg; Kierulf, Peter; Lyberg, Torstein. 2003. Sustained Prothrombotic profile after Hip Replacement Surgery. The Influence of Prolonged Prophylaxis with Dalteparin. Thrombosis and Haemostasis. 1: 971-975.
  • Ellingsen, D; Mykletun, Arnstein; Dahl, O; Klepp, O.; Bremnes, Roy Martin; Wist, Erik; Fosså, Sophie Dorothea. 2003. Gonadal hormones in longterm survivors 10 years after treatment for unilateral testicular cancer. European Urology. 44: 322-328.
  • Hovdenak, Nils; Karlsdottir, Åsa; Sørbye, Halfdan; Dahl, Olav. 2003. Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. Acta Oncologica. 42: 741-748.
  • Klepp, Olbjørn; Dahl, Olav; Cavallin-Stahl, E; Stierner, U; Cedermark, GC; Wist, Erik; Bremnes, Roy M. 2003. Risk-adapted brief adjuvant chemotherapy in clinical stage I (CSI) nonseminomatous germ cell testicular cancer (NSGCT). Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 22. 1 pages.
  • Kristiansen, Ivar Sønbø; Norderhaug, Inger; Bjerklund Johansen, Truls; Dahl, O. 2003. Brachytherapy for prostatic cancer: a systematic review of clinical and cost effectiveness. European Urology. 44: 40-46.
  • Muren, Ludvig Paul; Ekerold, R; Småland, Rune; Dahl, Olav. 2003. Treatment precision and treatment effect in conformal radiotherapy of urinary bladder cancer - preliminary results. Radiotherapy and Oncology. 68: S94-S94.
  • Muren, Ludvig; Småland, Rune; Dahl, Olav. 2003. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiotherapy and Oncology. 69: 291-304.
  • Nord, C; Ellingsen, D; Mykletun, A; Dahl, Olav; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Fosså, Sophie D. 2003. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. European Urology. 44. 7 pages.
  • Nord, Carina; Bjøro, Trine; Ellingsen, D; Mykletun, Arnstein; Dahl, Olav; Klepp, Olbjørn; Bremnes, Roy Martin; Wist, Erik; Fosså, Sophie Dorothea. 2003. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. European Urology. 44: 322-328.
  • Nord, Carina; Bjøro, Trine; Ellingsen, Dag; Mykletun, Arnstein; Dahl, Olav; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Fosså, Sophie D. 2003. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. European Urology. 44: 322-328.
  • Norderhaug, Inger; Dahl, Olav; Høisæter, Per Å.; Heikilä, Reino; Klepp, Olbjørn; Olsen, Dag Rune; Kristiansen, Ivar S.; Wæhre, Håkon; Bjerklund Johansen, Truls E. 2003. Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness. European Urology. 44: 40-46.
Reports and theses
  • Lehne, Gustav; Angelsen, Anders; Langberg, Carl W.; Dahl, Olav; Bremnes, Roy M.; Tandstad, Torgrim; Wahlqvist, Rolf; Haugnes, Hege Sagstuen. 2011. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av testikkelkreft. Helsedirektoratet. 109 pages.
  • Kaasa, S.; Vatten, L.; Vassenden, A.; Krüger, Ø.; Langmark, F.; Hoff, G.; Klemp Gjertsen, M.; Kvaløy, S.; Dahl, Olav; Johannessen, D.C. 2007. Kvalitetsregistre over kreftsykdommer. Sosial- og helsedirektoratet. IS-1523, Oslo. 14 pages.
Book sections
  • Christoffersen, Thoralf; Bruserud, Øystein; Fluge, Øystein; Lehne, Gustav; Dahl, Olav. 2016. Kreftbiologi og medikamentell terapi. Kapittel 1, pages 13-46. In:
    • Dahl, Olav; Lehne, Gustav; Christoffersen, Thoralf. 2016. Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. 661 pages. ISBN: 978-82-992331-4-9.
  • Dahl, Olav; Kvaløy, Stein Olav; Lehne, Gustav; Christoffersen, Thoralf. 2016. Medikamentell kreftbehandling. Kapittel 2, pages 47-56. In:
    • Dahl, Olav; Lehne, Gustav; Christoffersen, Thoralf. 2016. Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. 661 pages. ISBN: 978-82-992331-4-9.
  • Dahl, Olav; Nygaard, Randi; Brydøy, Marianne; Christoffersen, Thoralf; Lehne, Gustav. 2016. Bivirkninger. Kapittel 4, pages 67-97. In:
    • Dahl, Olav; Lehne, Gustav; Christoffersen, Thoralf. 2016. Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. 661 pages. ISBN: 978-82-992331-4-9.
  • Thoresen, G. Hege; Dahl, Olav; Christoffersen, Thoralf. 2010. L2 Legemidler i behandlingen av kreftsykdommer. L2, pages 775-820. In:
    • Fjeldstad, Trygve. 2010. Norsk legemiddelhåndbok for helsepersonell 2010. 2099 pages. ISBN: 9788290732108.
  • Christoffersen, Thoralf; Fluge, Øystein; Lehne, Gustav; Dahl, Olav. 2009. Kreftceller og kjemoterapi. Kap. 1, pages 13-37. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. 495 pages. ISBN: 978-82-9923312-5.
  • Christoffersen, Thoralf; Fluge, Øystein; Lehne, Gustav; Dahl, Olav. 2009. Kreftceller og kjemoterapi. Kapittel 1, pages 13-37. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein Olav; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. 495 pages. ISBN: 978-829923312-5.
  • Dahl, Olav; Kvaløy, Stein Olav; Lehne, Gustav; Baksaas, Ingebjørg; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Kapittel 2, pages 38-45. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein Olav; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. 495 pages. ISBN: 978-829923312-5.
  • Dahl, Olav; Kvaløy, Stein; Lehne, Gustav; Baksaas, Ingebjørg; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Kap. 2, pages 38-45. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. 495 pages. ISBN: 978-82-9923312-5.
  • Dahl, Olav; Lehne, Gustav. 2009. Cancer testis. Kap. 31, pages 404-411. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. 495 pages. ISBN: 978-82-9923312-5.
  • Dahl, Olav; Lilleby, W; Helle, Svein inge; Angelsen, A. 2009. Kreft i nyre, ureter, urinblære og prostata. Kap. 30, pages 396-403. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. 495 pages. ISBN: 978-82-9923312-5.
  • Dahl, Olav; Nygaard, R; Lehne, Gustav; Fosså, SD. 2009. Bivirkninger. Kap. 4, pages 56-74. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. 495 pages. ISBN: 978-82-9923312-5.
  • Dahl, Olav; Nygaard, Randi; Christoffersen, Thoralf; Lehne, Gustav; Fosså, Sophie Dorothea. 2009. Bivirkninger. Kapittel 4, pages 56-74. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein Olav; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. 495 pages. ISBN: 978-829923312-5.
  • Tveit, KM; Balteskard, L; Dahl, Olav. 2009. Gastrointestinal kreft. Kap. 27, pages 363-375. In:
    • Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein; Christoffersen, Thoralf. 2009. Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. 495 pages. ISBN: 978-82-9923312-5.
  • Christoffersen, Thoralf; Dahl, Olav. 2007. Legemidler i behandlingen av kreftsykdommer. Kapittel L2, pages 703-740. In:
    • Vilberg, Astri. 2007. Norsk legemiddelhåndbok for helsepersonell 2007. 1743 pages. ISBN: 978-82-90732-09-2.
  • Christoffersen, Thoralf; Dahl, Olav. 2007. Kreftsykdommer. Kapittel T2, pages 93-112. In:
    • Vilberg, Astri. 2007. Norsk legemiddelhåndbok for helsepersonell 2007. 1743 pages. ISBN: 978-82-90732-09-2.
  • Christoffersen, Thoralf; Dahl, Olav. 2004. Legemidler i behandlingen av kreftsykdommer. L2, pages 713-748. In:
    • Vilberg, A. 2004. Norsk legemiddelhåndbok for helsepersonell 2004. 1766 pages. ISBN: 82-90732-08-2.
  • Christoffersen, Thoralf; Dahl, Olav. 2004. Legemidler i behandling av kreftsykdommer. L2, pages 713-748. In:
    • Vilberg, Astri. 2004. Norsk legemiddelhåndbok for helsepersonell 2004. 1766 pages. ISBN: 82-90732-08-2.
  • Dahl, Olav; Christoffersen, Thoralf. 2004. Kreftsykdommer. T2 Kreftsykdommer, pages 93-113. In:
    • Vilberg, A. 2004. Norsk legemiddelhåndbok for helsepersonell 2004. 1766 pages. ISBN: 82-90732-08-2.
  • Dahl, Olav; Christoffersen, Thoralf. 2004. Kreftsykdommer. T2, pages 93-113. In:
    • Vilberg, Astri. 2004. Norsk legemiddelhåndbok for helsepersonell 2004. 1766 pages. ISBN: 82-90732-08-2.

More information in national current research information system (CRIStin)